Lilly's Zyprexa Warnings Were Adequate, Federal Judge Rules

NEW YORK - Eli Lilly & Co. adequately warned doctors of the metabolic risks associated with Zyprexa use, a New York federal judge ruled, granting the drug maker's motion for summary judgment in a negligence lawsuit. Quirarte v. Eli Lilly & Co., No. 07-1161 (E. D. N.Y.).

On Oct. 16, Chief Judge Jack B. Weinstein further ruled that Lilly adequately warned physicians of the risk of neuroleptic malignant syndrome associated with the schizophrenia drug.

Resendez suffered from serious mental illness since first exhibiting signs of schizophrenia in 1987 on his 18th birthday. Between then and the time of his death …